Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7801 to 7815 of 8915 results

  1. CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment (HTE4)

    We have moved Health technology evaluation 4 to become HealthTech guidance 663. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  2. ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment (HTE5)

    We have moved Health technology evaluation 5 to become HealthTech guidance 664. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  3. Artificial intelligence (AI) technologies to aid opportunistic detection of vertebral fragility fractures: early value assessment (HTE34)

    We have moved Health technology evaluation 34 to become HealthTech guidance 760. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  4. Digital platforms to support cardiac rehabilitation: early value assessment (HTE35)

    We have moved Health technology evaluation 35 to become HealthTech guidance 761. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  5. Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment (HTE6)

    We have moved Health technology evaluation 6 to become HealthTech guidance 665. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  6. Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment (HTE7)

    We have moved Health technology evaluation 7 to become HealthTech guidance 674. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  7. Digitally enabled therapies for adults with anxiety disorders: early value assessment (HTE9)

    We have moved health technology evaluation 9 to become HealthTech guidance 676. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  8. Digitally enabled therapies for adults with depression: early value assessment (HTE8)

    We have moved health technology evaluation 8 to become HealthTech guidance 675. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  9. Collagen injection for vocal cord augmentation (IPG130)

    We have moved interventional procedures guidance 130 to become HealthTech guidance 79. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  10. Low dose rate brachytherapy for localised prostate cancer (IPG132)

    We have moved interventional procedures guidance 132 to become HealthTech guidance 81. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  11. Insertion of extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women (IPG133)

    This guidance has been updated and replaced by NICE interventional procedures guidance 576.

    Withdrawn guidance

  12. Laparoscopic liver resection (IPG135)

    We have moved interventional procedures guidance 135 to become HealthTech guidance 83. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  13. Extracorporeal shock wave therapy for refractory tendinopathies (plantar fasciitis and tennis elbow) (IPG139)

    This guidance has been updated and replaced by NICE HealthTech guidance 201.

    Withdrawn guidance

  14. Photodynamic therapy for localised inoperable endobronchial cancer (IPG137)

    We have moved interventional procedures guidance 137 to become HealthTech guidance 85. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance

  15. Photodynamic therapy for bile duct cancer (IPG134)

    We have moved interventional procedures guidance 134 to become HealthTech guidance 82. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

    Withdrawn guidance